Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250217064758N1Phase 3Completed
Phase 3, randomised, double-blind trial comparing Propofol alone with Propofol + midazolam (2 arms). Primary endpoints: Time to reach Aldrete score of 10, Procedure time and 7 more. Started Apr 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250217064758N1.